List of Tables
Table 1. Global Live Brucellosis Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Live Brucellosis Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Live Brucellosis Vaccine Production Capacity (K Units) by Manufacturers in 2025
Table 4. Global Live Brucellosis Vaccine Production by Manufacturers (K Units), 2021–2026
Table 5. Global Live Brucellosis Vaccine Production Market Share by Manufacturers (2021–2026)
Table 6. Global Live Brucellosis Vaccine Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Live Brucellosis Vaccine Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Live Brucellosis Vaccine, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Live Brucellosis Vaccine Production Value, 2025
Table 10. Global Market Live Brucellosis Vaccine Average Price by Manufacturers (US$/Unit), 2021–2026
Table 11. Global Key Manufacturers of Live Brucellosis Vaccine, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Live Brucellosis Vaccine, Product Offerings and Applications
Table 13. Global Key Manufacturers of Live Brucellosis Vaccine, Date of Entry into the Industry
Table 14. Global Live Brucellosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Live Brucellosis Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Live Brucellosis Vaccine Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Live Brucellosis Vaccine Production Value Market Share by Region (2021–2026)
Table 19. Global Live Brucellosis Vaccine Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Live Brucellosis Vaccine Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Live Brucellosis Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Live Brucellosis Vaccine Production (K Units) by Region (2021–2026)
Table 23. Global Live Brucellosis Vaccine Production Market Share by Region (2021–2026)
Table 24. Global Live Brucellosis Vaccine Production (K Units) Forecast by Region (2027–2032)
Table 25. Global Live Brucellosis Vaccine Production Market Share Forecast by Region (2027–2032)
Table 26. Global Live Brucellosis Vaccine Market Average Price (US$/Unit) by Region (2021–2026)
Table 27. Global Live Brucellosis Vaccine Market Average Price (US$/Unit) by Region (2027–2032)
Table 28. Global Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 29. Global Live Brucellosis Vaccine Consumption by Region (K Units), 2021–2026
Table 30. Global Live Brucellosis Vaccine Consumption Market Share by Region (2021–2026)
Table 31. Global Live Brucellosis Vaccine Forecasted Consumption by Region (K Units), 2027–2032
Table 32. Global Live Brucellosis Vaccine Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 34. North America Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 35. North America Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 36. Europe Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 37. Europe Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 38. Europe Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 39. Asia Pacific Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 40. Asia Pacific Live Brucellosis Vaccine Consumption by Region (K Units), 2021–2026
Table 41. Asia Pacific Live Brucellosis Vaccine Consumption by Region (K Units), 2027–2032
Table 42. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 43. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 44. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 45. Global Live Brucellosis Vaccine Production (K Units) by Type (2021–2026)
Table 46. Global Live Brucellosis Vaccine Production (K Units) by Type (2027–2032)
Table 47. Global Live Brucellosis Vaccine Production Market Share by Type (2021–2026)
Table 48. Global Live Brucellosis Vaccine Production Market Share by Type (2027–2032)
Table 49. Global Live Brucellosis Vaccine Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Live Brucellosis Vaccine Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Live Brucellosis Vaccine Production Value Market Share by Type (2021–2026)
Table 52. Global Live Brucellosis Vaccine Production Value Market Share by Type (2027–2032)
Table 53. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2021–2026)
Table 54. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2027–2032)
Table 55. Global Live Brucellosis Vaccine Production (K Units) by Application (2021–2026)
Table 56. Global Live Brucellosis Vaccine Production (K Units) by Application (2027–2032)
Table 57. Global Live Brucellosis Vaccine Production Market Share by Application (2021–2026)
Table 58. Global Live Brucellosis Vaccine Production Market Share by Application (2027–2032)
Table 59. Global Live Brucellosis Vaccine Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Live Brucellosis Vaccine Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Live Brucellosis Vaccine Production Value Market Share by Application (2021–2026)
Table 62. Global Live Brucellosis Vaccine Production Value Market Share by Application (2027–2032)
Table 63. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2021–2026)
Table 64. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2027–2032)
Table 65. CZ Vaccines Live Brucellosis Vaccine Company Information
Table 66. CZ Vaccines Live Brucellosis Vaccine Specification and Application
Table 67. CZ Vaccines Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 68. CZ Vaccines Main Business and Markets Served
Table 69. CZ Vaccines Recent Developments/Updates
Table 70. MSD Live Brucellosis Vaccine Company Information
Table 71. MSD Live Brucellosis Vaccine Specification and Application
Table 72. MSD Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 73. MSD Main Business and Markets Served
Table 74. MSD Recent Developments/Updates
Table 75. Ceva Live Brucellosis Vaccine Company Information
Table 76. Ceva Live Brucellosis Vaccine Specification and Application
Table 77. Ceva Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 78. Ceva Main Business and Markets Served
Table 79. Ceva Recent Developments/Updates
Table 80. Colorado Serum Live Brucellosis Vaccine Company Information
Table 81. Colorado Serum Live Brucellosis Vaccine Specification and Application
Table 82. Colorado Serum Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 83. Colorado Serum Main Business and Markets Served
Table 84. Colorado Serum Recent Developments/Updates
Table 85. Tecnovax Live Brucellosis Vaccine Company Information
Table 86. Tecnovax Live Brucellosis Vaccine Specification and Application
Table 87. Tecnovax Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 88. Tecnovax Main Business and Markets Served
Table 89. Tecnovax Recent Developments/Updates
Table 90. Syva Live Brucellosis Vaccine Company Information
Table 91. Syva Live Brucellosis Vaccine Specification and Application
Table 92. Syva Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 93. Syva Main Business and Markets Served
Table 94. Syva Recent Developments/Updates
Table 95. Shchelkovo Biocombinat Live Brucellosis Vaccine Company Information
Table 96. Shchelkovo Biocombinat Live Brucellosis Vaccine Specification and Application
Table 97. Shchelkovo Biocombinat Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 98. Shchelkovo Biocombinat Main Business and Markets Served
Table 99. Shchelkovo Biocombinat Recent Developments/Updates
Table 100. Jinyu Baoling Live Brucellosis Vaccine Company Information
Table 101. Jinyu Baoling Live Brucellosis Vaccine Specification and Application
Table 102. Jinyu Baoling Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 103. Jinyu Baoling Main Business and Markets Served
Table 104. Jinyu Baoling Recent Developments/Updates
Table 105. Biovet Live Brucellosis Vaccine Company Information
Table 106. Biovet Live Brucellosis Vaccine Specification and Application
Table 107. Biovet Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 108. Biovet Main Business and Markets Served
Table 109. Biovet Recent Developments/Updates
Table 110. CAVAC Live Brucellosis Vaccine Company Information
Table 111. CAVAC Live Brucellosis Vaccine Specification and Application
Table 112. CAVAC Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 113. CAVAC Main Business and Markets Served
Table 114. CAVAC Recent Developments/Updates
Table 115. VETAL Live Brucellosis Vaccine Company Information
Table 116. VETAL Live Brucellosis Vaccine Specification and Application
Table 117. VETAL Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 118. VETAL Main Business and Markets Served
Table 119. VETAL Recent Developments/Updates
Table 120. Indian Immunologicals Live Brucellosis Vaccine Company Information
Table 121. Indian Immunologicals Live Brucellosis Vaccine Specification and Application
Table 122. Indian Immunologicals Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 123. Indian Immunologicals Main Business and Markets Served
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Dollvet Live Brucellosis Vaccine Company Information
Table 126. Dollvet Live Brucellosis Vaccine Specification and Application
Table 127. Dollvet Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 128. Dollvet Main Business and Markets Served
Table 129. Dollvet Recent Developments/Updates
Table 130. Hester Biosciences Live Brucellosis Vaccine Company Information
Table 131. Hester Biosciences Live Brucellosis Vaccine Specification and Application
Table 132. Hester Biosciences Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 133. Hester Biosciences Main Business and Markets Served
Table 134. Hester Biosciences Recent Developments/Updates
Table 135. Qilu Animal Health Live Brucellosis Vaccine Company Information
Table 136. Qilu Animal Health Live Brucellosis Vaccine Specification and Application
Table 137. Qilu Animal Health Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 138. Qilu Animal Health Main Business and Markets Served
Table 139. Qilu Animal Health Recent Developments/Updates
Table 140. Auleon Biologicals Live Brucellosis Vaccine Company Information
Table 141. Auleon Biologicals Live Brucellosis Vaccine Specification and Application
Table 142. Auleon Biologicals Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 143. Auleon Biologicals Main Business and Markets Served
Table 144. Auleon Biologicals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Live Brucellosis Vaccine Distributors List
Table 148. Live Brucellosis Vaccine Customers List
Table 149. Live Brucellosis Vaccine Market Trends
Table 150. Live Brucellosis Vaccine Market Drivers
Table 151. Live Brucellosis Vaccine Market Challenges
Table 152. Live Brucellosis Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live Brucellosis Vaccine
Figure 2. Global Live Brucellosis Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Live Brucellosis Vaccine Market Share by Type: 2025 vs 2032
Figure 4. Strain RB-51 Product Picture
Figure 5. Strain S19 Product Picture
Figure 6. Strain S2 Product Picture
Figure 7. Strain A19 Product Picture
Figure 8. Strain Rev. I Product Picture
Figure 9. Global Live Brucellosis Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Live Brucellosis Vaccine Market Share by Application: 2025 vs 2032
Figure 11. Cattle
Figure 12. Sheep
Figure 13. Pig
Figure 14. Others
Figure 15. Global Live Brucellosis Vaccine Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Live Brucellosis Vaccine Production Value (US$ Million), 2021–2032
Figure 17. Global Live Brucellosis Vaccine Production Capacity (K Units), 2021–2032
Figure 18. Global Live Brucellosis Vaccine Production (K Units), 2021–2032
Figure 19. Global Live Brucellosis Vaccine Average Price (US$/Unit), 2021–2032
Figure 20. Live Brucellosis Vaccine Report Years Considered
Figure 21. Live Brucellosis Vaccine Production Share by Manufacturers in 2025
Figure 22. Global Live Brucellosis Vaccine Production Value Share by Manufacturers (2025)
Figure 23. Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Top 5 and Top 10 Global Players: Market Share by Live Brucellosis Vaccine Revenue in 2025
Figure 25. Global Live Brucellosis Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global Live Brucellosis Vaccine Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 27. Global Live Brucellosis Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 28. Global Live Brucellosis Vaccine Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 29. North America Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 30. Europe Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 31. China Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 32. Japan Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 33. Global Live Brucellosis Vaccine Consumption by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 34. Global Live Brucellosis Vaccine Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 35. North America Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 36. North America Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 37. U.S. Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 38. Canada Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 39. Europe Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 40. Europe Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 41. Germany Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 42. France Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 43. U.K. Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 44. Italy Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 45. Russia Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 46. Asia Pacific Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 47. Asia Pacific Live Brucellosis Vaccine Consumption Market Share by Region (2021–2032)
Figure 48. China Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 49. Japan Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 50. South Korea Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 51. China Taiwan Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 52. Southeast Asia Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 53. India Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 54. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 55. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 56. Mexico Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 57. Brazil Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 58. Turkey Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 59. GCC Countries Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 60. Global Production Market Share of Live Brucellosis Vaccine by Type (2021–2032)
Figure 61. Global Production Value Market Share of Live Brucellosis Vaccine by Type (2021–2032)
Figure 62. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 63. Global Production Market Share of Live Brucellosis Vaccine by Application (2021–2032)
Figure 64. Global Production Value Market Share of Live Brucellosis Vaccine by Application (2021–2032)
Figure 65. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 66. Live Brucellosis Vaccine Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
